Ignite Creation Date:
2024-05-06 @ 12:11 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01515527
Status:
RECRUITING
Last Update Posted:
2024-06-27
First Post:
2012-01-13
Brief Title:
Cladribine Plus Low Dose Cytarabine LDAC Alternating With Decitabine in Patients With Acute Myeloid Leukemia AML or High-Risk Myelodysplastic Syndrome MDS
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2026-02-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-01-13
First Submit QC Date:
January 18 2012
Study First Post Date:
2012-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-25
Last Update Post Date:
2024-06-27
Last Update Post Date Type:
ACTUAL